Mario Strazzabosco

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Edoardo G. Giannini

University of Genoa

ITALY

View details

MingDe Lin

Adjunct Associate Professor

Yale University School of Medicine

UNITED STATES

View details

Paolo Simioni

Padua University Hospital

ITALY

View details

Rafael Duran

SWITZERLAND

View details

Lynn Jeanette Savic

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

View details

LUCA FABRIS

Yale University

UNITED STATES

View details

Massimiliano Cadamuro

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mario Strazzabosco

Research Interests

Explore related searches

Contact this professor

Articles (16)

Second‐Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta‐Analysis

May we actually help clinicians select the best systemic treatment for patients with intermediate‐stage hepatocellular carcinoma?

Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice

It could happen in your backyard

Community-Level Factors Associated with Hepatocellular Carcinoma Incidence and Mortality: An Observational Registry Study

Cost-effectiveness analysis: The missing factor in the management of HCC

Cell-matrix interactions control biliary organoid polarity, architecture, and differentiation

Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCC

Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysis

Reply: Novel antidiabetic drugs and the risk for HCC. What else to expect from these “wonderful” drug classes?

Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook

Molecular determinants of peri‐apical targeting of inositol 1,4,5‐trisphosphate receptor type 3 in cholangiocytes

Bile acids and their receptors: modulators and therapeutic targets in liver inflammation

Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI

Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma

Dysregulation of the Scribble/YAP/β‐catenin axis sustains the fibroinflammatory response in a PKHD1 −/− mouse model of congenital hepatic fibrosis

Collaborators (7)

Edoardo G. Giannini

MingDe Lin

Paolo Simioni

Rafael Duran

Lynn Jeanette Savic

LUCA FABRIS

Massimiliano Cadamuro

Make your next move.